Published in Gynakol Rundsch on January 01, 1991
Nongenital cancers metastatic to the ovary. Gynecol Oncol (1992) 1.64
Tumor angiogenesis as a prognostic factor in ovarian carcinoma: quantification of endothelial immunoreactivity by image analysis. Cancer (1997) 1.55
Chemotherapy versus radiotherapy versus observation for high-risk cervical carcinoma after radical hysterectomy: A randomized, prospective, multicenter trial. Gynecol Oncol (1999) 1.54
Exfoliative cytology of a lymphoepithelioma-like carcinoma in a cervical smear. A case report. Acta Cytol (1999) 1.47
Arteriovenous malformations of the uterus. Obstet Gynecol (1989) 1.44
Patterns of pelvic and paraaortic lymph node involvement in ovarian cancer. Gynecol Oncol (1991) 1.41
Histopathology of the fallopian tube after local instillation of hyperosmolar glucose solution for unruptured tubal pregnancy. Fertil Steril (1993) 1.39
Leiomyosarcoma of the uterus: a clinicopathologic multicenter study of 71 cases. Gynecol Oncol (1999) 1.34
Prognostic parameters in endometrial stromal sarcoma: a clinicopathologic study in 31 patients. Gynecol Oncol (2001) 1.33
Global sequence diversity of BRCA2: analysis of 71 breast cancer families and 95 control individuals of worldwide populations. Hum Mol Genet (1999) 1.24
Preoperative CA 125: an independent prognostic factor in patients with stage I epithelial ovarian cancer. Obstet Gynecol (1995) 1.17
Clear cell carcinoma of the uterine cervix: pathology and prognosis in surgically treated stage IB-IIB disease in women not exposed in utero to diethylstilbestrol. Gynecol Oncol (2000) 1.14
Lymphogenous metastasis in the primary carcinoma of the fallopian tube. Gynecol Oncol (1994) 1.08
Carcinoma of the cervix: analysis of complications after primary external beam radiation and Ir-192 HDR brachytherapy. Radiother Oncol (1997) 1.05
Successful endoscopical sealing of malignant esophageotracheal fistulae by using a covered self-expandable stenting system. Eur J Cardiothorac Surg (2001) 1.05
Primary carcinoma of the fallopian tube--a retrospective analysis of 115 patients. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Br J Cancer (1993) 1.04
Lymphadenectomy in stage I ovarian cancer. Am J Obstet Gynecol (1994) 1.03
Consolidation radiotherapy after carboplatin-based chemotherapy in radically operated advanced ovarian cancer. Gynecol Oncol (1999) 1.01
Ovarian cancer in elderly patients: carboplatin and pegylated liposomal doxorubicin versus carboplatin and paclitaxel in late relapse: a Gynecologic Cancer Intergroup (GCIG) CALYPSO sub-study. Ann Oncol (2011) 1.00
[Special morphological aspects of vulvar carcinoma in its precancerous and early stages (author's transl)]. Arch Gynakol (1974) 1.00
Spontaneous vaginal delivery in the birth-chair versus in the conventional dorsal position: a matched controlled comparison. Wien Klin Wochenschr (2001) 0.98
Prognostic factors and operative treatment of stages IB to IIB cervical cancer. Am J Obstet Gynecol (1987) 0.97
Pelvic and paraaortic lymphocysts after radical surgery because of cervical and ovarian cancer. Am J Obstet Gynecol (1989) 0.97
Cervical intraepithelial neoplasia III: long-term outcome after cold-knife conization with clear margins. Obstet Gynecol (2001) 0.96
Thrombocytosis as a prognostic factor in endometrial carcinoma. Gynecol Oncol (1998) 0.94
Epoetin alfa in platinum-treated ovarian cancer patients: results of a multinational, multicentre, randomised trial. Br J Cancer (2006) 0.93
[Treatment of primary cancer of the fallopian tube]. Geburtshilfe Frauenheilkd (1990) 0.93
Prognostic factors in surgically treated stage ib-iib cervical carcinomas with special emphasis on the importance of tumor volume. Gynecol Oncol (2001) 0.93
Solitary metastasis in the tarsus preceding the diagnosis of primary endometrial cancer. A case report. Eur J Gynaecol Oncol (1995) 0.92
Expression of oestrogen and progesterone receptors in low-grade endometrial stromal sarcomas. Br J Cancer (2000) 0.91
Vesicocutaneous fistula mimicking an abdominal wall abscess 2 years after radical abdominal hysterectomy. Gynecol Oncol (2003) 0.91
Interferon-gamma in combination with carboplatin and paclitaxel as a safe and effective first-line treatment option for advanced ovarian cancer: results of a phase I/II study. Int J Gynecol Cancer (2006) 0.91
[Wound rupture after Misgav-Ladach cesarean section: a case report]. Gynakol Geburtshilfliche Rundsch (2004) 0.90
Carboplatin-paclitaxel-induced leukopenia and neuropathy predict progression-free survival in recurrent ovarian cancer. Br J Cancer (2011) 0.90
Pelvic lymphadenectomy in operative treatment of ovarian cancer. Am J Obstet Gynecol (1986) 0.89
Preoperative thrombocytosis is an independent prognostic factor in stage III and IV endometrial cancer. Anticancer Res (2001) 0.89
Lymphadenectomy in primary carcinoma of the Fallopian tube. Cancer Lett (1999) 0.89
The predictive value of a combination of tumor markers in monitoring patients with ovarian cancer. Cancer (1987) 0.89
Computed tomography or ultrasonically guided pigtail catheter drainage in multiloculated pleural empyema: a recommended procedure? Respirology (2000) 0.88
Pretreatment hemoglobin, platelet count, and prognosis in endometrial carcinoma. Int J Gynecol Cancer (2001) 0.87
Inguinal lymph node metastasis as the only manifestation of lymphatic spread in ovarian cancer: A case report. Gynecol Oncol (1999) 0.86
Are endometrial carcinoma cells disseminated at hysteroscopy functionally viable? Gynecol Oncol (2001) 0.86
The clinical value of serum concentrations of cancer antigen 125 in patients with primary fallopian tube carcinoma: a multicenter study. Cancer (2000) 0.86
Significance of pretreatment serum hemoglobin and survival in epithelial ovarian cancer. Oncol Rep (2000) 0.86
A comparative analysis of management and prognosis in stage I and II fallopian tube carcinoma and epithelial ovarian cancer. Br J Cancer (1994) 0.86
Prognostic factors in patients with carcinoma of the uterine cervix treated with external beam irradiation and IR-192 high-dose-rate brachytherapy. Int J Radiat Oncol Biol Phys (1998) 0.86
Cold-knife conization versus loop excision: histopathologic and clinical results of a randomized trial. Gynecol Oncol (1994) 0.85
Long-term control of bone marrow carcinosis and severe thrombocytopenia with standard-dose chemotherapy in a breast cancer patient: a case report. Anticancer Res (2006) 0.85
Radical lymphadenectomy in the primary carcinoma of the fallopian tube. Arch Gynecol Obstet (1993) 0.84
[Localisation of beginning invasive cancer of the cervix]. Arch Gynakol (1973) 0.83
Primary serous papillary carcinoma of the peritoneum: a report of 18 patients. Eur J Gynaecol Oncol (1997) 0.83
Management and prognosis of primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Gynecol Obstet Invest (1999) 0.83
Cord blood oxygen saturation in vigorous infants at birth: what is normal? BJOG (2000) 0.82
The prognostic significance of peritoneal seeding and size of postsurgical residual in patients with stage III epithelial ovarian cancer treated with surgery, chemotherapy, and high-dose radiotherapy. Gynecol Oncol (1999) 0.82
Prognostic significance of preoperative DNA flow cytometry in surgically-treated cervical cancer. Eur J Gynaecol Oncol (2003) 0.82
Microinvasive carcinoma of the uterine cervix (International Federation of Gynecology and Obstetrics Stage IA). Cancer (1991) 0.82
Pneumopericardium due to intrapericardial perforation of a gastric ulcer. Eur J Cardiothorac Surg (2003) 0.82
The spread of ovarian cancer. Baillieres Clin Obstet Gynaecol (1989) 0.82
Selective decrease in serum immunoglobulin G1. A tissue nonspecific tumor marker detecting early stages of gynecologic malignant disease with high efficiency. Cancer (1996) 0.82
Local spread and lymph node involvement in cervical cancer. Obstet Gynecol (1978) 0.81
[Pseudomyxoma peritonei caused by proliferating mucinous adenoma of the fimbria mucosa]. Geburtshilfe Frauenheilkd (1990) 0.81
Erythropoietin treatment under polychemotherapy in patients with gynecologic malignancies: a prospective, randomized, double-blind placebo-controlled multicenter study. Gynecol Oncol (1997) 0.81
In vitro chemosensitivity testing in the treatment of ovarian carcinoma. Arch Gynecol Obstet (1989) 0.81
Pelvic lymphadenectomy in the surgical treatment of endometrial cancer. Gynecol Oncol (1993) 0.81
Prognostic factors in cervical cancer. Eur J Obstet Gynecol Reprod Biol (1997) 0.81
Comparison of 18F-FDG and 67Ga-citrate in sarcoidosis imaging. Nuklearmedizin (2008) 0.81
The relevance of adjuvant therapy in primary carcinoma of the fallopian tube, stages I and II: irradiation vs. chemotherapy. Int J Radiat Oncol Biol Phys (2000) 0.80
[The importance of lymphadenectomy for therapie of ovarian carcinoma (author's transl)]. Geburtshilfe Frauenheilkd (1981) 0.80
The significance of pelvic and para-aortic lymphadenectomy in the operative treatment of ovarian cancer. Baillieres Clin Obstet Gynaecol (1989) 0.80
A 15-year overview of management and prognosis in primary fallopian tube carcinoma. Austrian Cooperative Study Group for Fallopian Tube Carcinoma. Eur J Cancer (1998) 0.80
Long-term survival of a patient with fallopian tube cancer presenting with a supraclavicular mass. Anticancer Res (2001) 0.79
[Chemotherapy of ovarian cancer]. Gynakol Rundsch (1980) 0.79
[Surgical tumor reduction in extensive ovarian cancer]. Onkologie (1985) 0.79
[Importance of the composition of various combination regimens in the chemotherapy of metastatic breast cancer]. Dtsch Med Wochenschr (1987) 0.79
Malignant paraganglioma of the uterus. Virchows Arch A Pathol Anat Histopathol (1992) 0.79
Chemotherapy for advanced and/or recurrent cervical cancer. Arch Gynecol (1987) 0.79
Do primiparas aged 40 years or older carry an increased obstetric risk? Prev Med (1999) 0.79
On the relevance of "second-line" cytotoxic chemotherapy in patients with metastatic breast cancer resistant to standard combinations. Wien Klin Wochenschr (1986) 0.79
Characterization of in vitro chemosensitivity of perioperative human ovarian malignancies by adenosine triphosphate chemosensitivity assay. Am J Obstet Gynecol (1991) 0.79